← Leaderboards
Patrycja Marta Dubielecka-Szczerba
Rhode Island Hospital
$3,859,763
Attributed
$3,859,763
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,047,104 · 5
By mechanism
R01$1,969,215 · 1
P30$1,963,166 · 3
P20$1,114,723 · 1
Top collaborators
No co-investigators on record.
Most similar at Rhode Island Hospital
Same institution · by research overlap
- Qian Chen$25,602,425
- Olin D. Liang$4,082,589
- Christian Franck$1,040,010
- Craig Thomas Lefort$4,266,225
- Joe A. McDonough$471,266
Others in their field
Other Emerging Leaders on “Stem Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Bronwen Shaw · Medical College Of Wisconsin$24,584,971
- Jacob Ruff · Cornell University$22,500,000
- James Dale Berry · Brigham And Women'S Hospital$20,303,231
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Elke Arenholz · Cornell University$14,750,000
Research focus
Stem CellsNovel Therapeutic InterventionInflammatoryTranscriptSignal TransductionPathway InteractionsStat3 GeneAdaptor Signaling ProteinMaintenanceSignal PathwayGranulocyteMyeloproliferative DiseaseProteinsPathogenesisPrimary MyelofibrosisHematopoietic Stem CellsMalignant - DescriptorPathogenicityMouse ModelCommunicationPhenotypeCancer Stem CellSrc-Family KinasesAffect
Grant awards (17)
Stem Cells and Aging$1,187,341
P30 · FY2025 · GM · contact PI
Administrative Core COBRE Phase III Stem Cells and Aging$383,839
P30 · FY2025 · GM · contact PI
Pilot Projects Program$195,186
P30 · FY2024 · GM · contact PI
The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation$360,922
R01 · FY2023 · CA · contact PI
Pilot Projects Program$196,800
P30 · FY2023 · GM · contact PI
The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation$360,922
R01 · FY2022 · CA · contact PI
The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation$10,895
R01 · FY2022 · CA · contact PI
The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation$368,288
R01 · FY2021 · CA · contact PI
Interrogating the Role of Abelson Interactor 1 in Age-Related Myelofibrosis$217,678
P20 · FY2021 · GM · contact PI
The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation$71,513
R01 · FY2021 · CA · contact PI
The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation$368,288
R01 · FY2020 · CA · contact PI
Interrogating the Role of Abelson Interactor 1 in Age-Related Myelofibrosis$220,180
P20 · FY2020 · GM · contact PI
The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation: Diversity Supplement$60,099
R01 · FY2020 · CA · contact PI
The role of Abelson interactor 1 (Abi-1) in hematopoietic stem cell self-renewal and malignant transformation$368,288
R01 · FY2019 · CA · contact PI
Interrogating the Role of Abelson Interactor 1 in Age-Related Myelofibrosis$222,618
P20 · FY2019 · GM · contact PI
Interrogating the Role of Abelson Interactor 1 in Age-Related Myelofibrosis$225,550
P20 · FY2018 · GM · contact PI
Interrogating the Role of Abelson Interactor 1 in Age-Related Myelofibrosis$228,697
P20 · FY2017 · GM · contact PI